Passive targeting with liposomal drug carriers

Drug Delivery System

Volumn 14, Issue 6, 1999, Pages 433-447

  Maruyama, Kazuo ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

drug delivery system; EPR effect; liposomes; passive targeting; polyethyleneglycol

Indexed keywords

EID: 84901819328     PISSN: 09135006     EISSN: 18812732     Source Type: Journal    
DOI: 10.2745/dds.14.433     Document Type: Article

References (75)

1. Bangham AD, Standish M, Watkins J : Diffusion on univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13 : 238-252, 1965.
2. Liposomes : from biophysics to therapeutics.(ed. Ostro MJ), Marcel Dekker Inc. New York, 1987.
3. Lasic DD (ed.) : Liposomes : from physics to applications. Elsevier, Amsterdam, 1993.
4. Gregoriadis G (ed.) : Liposome Technology, 2nd ed. CRC Press, Boca Raton, FL, 1993.
5. Woodle MC, Storni G (eds.) : Long circulating liposomes : Old drugs, New Therapeutics, Springer, Berlin, 1997.
6. Lasic DD, Martin F (eds.) : Stealth Liposomes. CRC Press, Boca Raton, 1995.
7. Gregoriadis G, Neerunjun ED : Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected in to rat. Possible therapeutic applications. Eur. J. Biochem. 47 : 179-185, 1974.
8. Bonte F, Juliano RL : Interactions of liposomes with serum proteins. Chem. Phys. Lipids 40 : 359-372, 1986.
9. Derksen JTP, Morselt HWM, Scherphof GL : Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim. Biophys. Acta 971 : 127-136, 1988.
10. Hus MJ, Juliano RL : Interactions of liposomes with the reticuloendothelial system. II. Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim. Biophys. Acta 720 : 411-419, 1982.
11. Roerdink F, Wassef NM, Richardson EC, Alving CR : Effects of negatively charged lipids on phagocytosis of Liposomes opsonized by complement. Biochim. Biophys. Acta 734 : 33-39, 1983.
12. Chonn A, Semple SC, Cullis PR : Separation of large unilamellar liposomes from blood components by a spin column procedure : towards identifying plasma proteins which mediate liposome clearance in vivo. Biochdm. Biophys. Acta 1070 : 215-222, 1991.
13. Kiwada H, Obara S, Nishiwaki H, Kato Y : Studies on the uptake mechanism of liposomes by perfused rat liver. I. An investigation of effluent profiles with perfusate containing no blood component. Chem. Pharm. Bull. 34 : 1249-1256, 1986.
14. Kiwada H, Miyajima T, Kato Y : Studies on the uptake mechanism of liposomes by perfused rat liver. II. An indispensable factor for liver uptake in serum. Chem. Pharm. Bull. 35 : 1189-1195, 1987.
15. Chonn A, Cullis PR, Devine DV : The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146 : 4234-4241, 1991.
16. Funato K, Yoda R, Kiwada H : Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochim. Biophys. Acta 1103 : 198-204, 1992.
17. Chonn A, Cullis PR, Devine D : The role of surface change in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146 : 4234-4241, 1991.
18. Nishikawa K, Arai H, Inoue K : Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J. Biol. Chem. 265 : 5226-5231, 1990.
19. Senior J, Crawley JCW, Gregoriadis G : Tissue distribution of liposomes exhibiting long harf-lives in the circulation after intravenous injection. Biochim. Biophys. Acta 839 : 1-8, 1985.
20. Kirby C, Gregoriadis G : The effect of lipid composition of small unilamellar liposomes containing melphalan and vincristine on drug clearance after injection into mice. Biochem. Pharma. 32 : 609-615, 1983.
21. Gotfredsen CF, Frokjaer S, Hjorth EL, Jorgensen KD, Guisset MCD : Disposition of intact liposomes of different composition and liposomal degradation products. Biochem. Pharma. 32 : 3381-3387, 1983.
22. Hwang KJ, Luk KFS, Beaumier PL : Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes. A kinetic study. Proc. Natl. Acad. Sci. USA 77 : 4030-4034, 1980.
23. Senior J, Gregoriadis G : Stability of small unilamellar liposomes in serum and clearance from the circulation. The effect of the phospholipid and cholesterol components. Life Sciences 30 : 2123-2136, 1982.
24. Harashima H, Sakata K, Funato K, Kiwada H : Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm. Res. 11 : 402-406, 1994.
25. Juliano RL, Stamp D : The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem. Biophys. Res. Comm. 63 : 651-658, 1975.
26. Gregoriadis G, Kirby C, Senior J : Optimization of liposome behavior in vivo. Biol. Cell. 47 : 11-18, 1983.
27. Scherphof G, Roerdink F, Dijkstra J, Ellens H, Zanger R et al. : Uptake of liposomes by rat and mouse hepatocytes and kupffer cells. Biol. Cell. 47 : 47-58, 1983.
28. Webb MS, Harasym TO, Bally MB, Mayer LD : Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine na d human tumour models. Br. J. Cancer 72 : 896-904, 1995.
29. Alving CR, Steck EA, Chapman Jr. WL, Waits VB, Hendricks LD et al. : Therapy of leishmaniasis : superior efficacies of liposome-encapsulated drugs. Proc. Natl. Acad. Sci. USA 75 : 2959-2963, 1978.
30. Papahadjopoulos D, Gabizon A : Targeting of liposomes to tumor ceells, in vivo. Ann. NY Acad. Sci. 507 : 64-74, 1987.
31. Allen TM, Chonn A : Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 223 : 42-46, 1987.
32. Klibanov AL, Maruyama K, Huang L : Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268 : 235-237, 1990.
33. Blume G, Ceve G : Liposomes for the sustained drug release in vivo. Biochim. Biophys. Acta 1029 : 91-97, 1990.
34. Allen TM, Hansen C, Martin FL et al. : Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066 : 29-36, 1991.
35. Yamauchi H, Kikuchi H, Yachi K, Sawada M, Tomikawa M et al. : Effects of glycophorin and ganglioside GM3 on the blood circulation and tissue distribution of liposomes in rats. Int. J. Pharm. 90 : 73-79, 1993.
36. Allen TM, Hansen C, Rutledge J : Liposomes with prolonged circulation times : factors affecting uptake by reticuloendothelial and other tissue. Biochim. Biophys. Acta 981 : 27-35, 1989.
37. Yamauchi H, Yano T, Kato T, Tanaka I, Nakabayashi S et al. : Effect of sialic acid derivative on long circulation time and tumor concentration of liposomes. Int. J. Pharm. 113 : 141-144, 1995.
38. Namba Y, Sakakibara T, Masada M, Ito F, Oku N : Glucronate-modified liposomes with prolonged circulation time. Chem. Pharm. Bull. 38 : 1663-1666, 1990.
39. Gabizon A, Papahadjopoulos D : Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 85 : 6949-6953, 1988.
40. Gabizon A, Price DC, Huberty J, Rresalier PS, Papahadjopoulos D : Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors. Biodistribution and imaging studies. Cancer Res. 50 : 6371-5378, 1990.
41. Yuda T, Pongpaibul Y, Maruyama K, Iwatsuru M : Activity of amphipathic polyethylene glycols to prolong the circulation time of liposomes. J. Pharm. Sci. Jpn. 59 : 32-42, 1999.
42. Needham D, Mcintosh TJ, Lasic DD : Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim. Biophys. Acta 1108 : 40-48, 1992.
43. Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G : Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation : studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta 1062 : 77-82, 1991.
44. Torchilin VP, Papisov MI : Why do polyethylene glycol-coated liposomes circulation so long? J. Liposome Res. 4 : 725-739, 1994.
45. Lasic DD, Martin FJ, Gabizon A, Huang SK, Papahadjopoulos D : Sterically stabilized liposomes. A hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1070 : 187-192, 1991.
46. Woodle MC, Matthay KK, Newman MS, Hidayat JE, Collins LR et al. : Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim. Biophys. Acta 1105 : 193-200, 1992.
47. Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A : Liposomes containing synthetic lipid derivatives of poly(ethyleneglycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066 : 29-36, 1991.
48. Maruyama K, Yuda T, Okamoto A, Ishikura C, Kojima S et al. : Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilarnellar liposomes. Chem. Pharm. Bull. 39 : 1620-1622, 1991.
49. Allen TM, Austin GA, Chonn A, Lin L, Lee KC : Uptake of liposomes by cultured mouse bone marrow macrophages. Influence of liposome composition and size. Biochim. Biophys. Acta 1061 : 56-64, 1991.
50. Uster PS, Allen TM, Daniel BE, Mendez CJ, Newman MS et al. : Insertion of poly(ethylene glycol) derived phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett. 386 : 243-246, 1996.
51. Matsumura Y, Maeda H : A new concept for macromnIecular therapeutics in cancer chemotherapy : Mechanism and antitumor agent smancs. Cancer Res. 46 : 6387-6392, 1986.
52. Kohn S, Nagy JA, Dvorak HF, Dvorak AM : Pathways of macromolecular tracer transport across venules and small veins. Lab. Invst. 67 : 596-607, 1992.
53. Jain RK : Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 6 : 559-593, 1987.
54. Maeda H, Seymour LW, Miyamoto Y : Conjugates of anticancer agents and polymers : Advantages of macromolecular therapeutics in vivo. Bioconjugate Chem. 3 : 351-362, 1992.
55. Dvorak HF, Nagy JA, Dvorak JT et al. : Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Phathol. 133 : 95-109, 1988.
56. Jain RK, Gerlowski LE : Extravascular transport in normal and tumor tissue. Crit. Rev. Oncol. Hematol. 5 : 115-170, 1986.
57. Suzuki M, Hori K, Abe I : A new approach to cancer chemotherapy: Selective enhancement of tumor blood flow with angiotensin II. J. Natl. Cancer Inst. 67 : 663-669, 1981.
58. Jain RK : Transport of molecules across tumor casculature. Cancer Metastasis Rev. 6 : 559-593, 1987.
59. Dvorak HF, Nagy JA, Berse B et al. : Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann. NY. Acad. Sci. 667 : 101-111, 1992.
60. Dvorak HF, Brown LF, Detmar M, Dvorak AM : Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146 : 1029-1039, 1995.
61. Unezaki S, Maruyama K, Ishida O et al. : Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic poly(ethylene glycol). Int. J. Pharm. 126 : 41-48, 1995.
62. Unezaki S, Maruyama K, Hosoda J et al. : Direct measurement of extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int. J. Pharm. 144 : 11-17, 1996.
63. Ishida O, Maruyama K, Sasaki K, Iwatsuru M : Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int. J. Pharm. (in press).
64. Coukell A, Spencer C : Polyethylene glycol-liposomal doxorubicin. Drugs 53 : 520-538, 1997.
65. Unezaki S, Maruyama K, Takahashi N et al. : Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia. Pharm. Res. 11 : 1180-1185, 1994.
66. Ishida O, Maruyama K, Yanagie H, Eriguchi M, Iwatsuru M : Targeting-chemotherapy to solid tumors with long-circulating thermosensitive liposomes and local hyperthermia. Jpn. J. Cancer Res., (in press).
67. Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L : Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1062 : 142-148, 1991.
68. Mori A, Klibanov AL, Torchilin VP, Huang L : Influence of the stcric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett. 284 : 263-266, 1991.
69. Maruyama K, Takizawa T, Yuda T et al. : Targetability of novel immunoliposomes modified with amphipathic polyethyleneglycols conjugated at their distal terminals to monoclonal antibodies. Biochim Biophys. Acta 1234 : 74-80, 1995.
70. Maruyama K, Takahashi N, Tagawa T et al. : Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into target solid tumors in vivo. FEBS Lett. 413 : 177-180, 1997.
71. Jain RK : Barriers to drug delivery in solid tumors. Scientific American 271 : 42-49, 1994.
72. Hori K, Suzuki M, Abe I, Saito S, Sato H : Increase in tumor vascular area due to increased blood flow by angiotensin II in rats. J. Natl. Cancer Inst. 74 : 453-459, 1985.
73. Li CJ, Miyamoto Y, Kojima Y, Maeda H : Augmentation of tumor delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure. Br. J. Cancer 67 : 975-980, 1993.
74. Kono K, Zenitani K, Takagishi T : Novel pH-sensitive liposomes : liposomes bearing a polyethylene glycol derivative with carboxyl groups. Biochim. Biophys. Acta 1193 : 1-9, 1994.
75. Kono K, Igawa T, Takagishi T : Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive polyethylene glycol derivative. Biochim. Biophys. Acta 1325 : 143-154, 1997.